TRANSFER-FACTOR FOR THE TREATMENT OF HBSAG-POSITIVE CHRONIC ACTIVE HEPATITIS

被引：0
|
作者：
RODA, E
VIZA, D
PIZZA, G
MASTROROBERTO, L
PHILLIPS, J
DEVINCI, C
BARBARA, L
机构：
[1] OSPED M MALPIGHI,I-40139 BOLOGNA,ITALY
[2] UNIV BOLOGNA,MED CLIN 3,I-40126 BOLOGNA,ITALY
[3] FAC MED PARIS,IMMUNOBIOL LAB,F-75006 PARIS,FRANCE
来源：
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE | 1985年 / 178卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：468 / 475
页数：8
相关论文
共 50 条
  • [31] TERMINATION OF IMMUNOSUPPRESSIVE THERAPY IN HBSAG-POSITIVE CHRONIC HEPATITIS
    HESS, G
    SLUSARCZYK, J
    ZUMBUSCHENFELDE, KHM
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1985, 23 (09): : 446 - 446
  • [32] INVITRO SYNTHESIS OF IGG AND IGM IN PATIENTS WITH HBSAG-POSITIVE AND HBSAG-NEGATIVE CHRONIC ACTIVE HEPATITIS
    TRIOLO, G
    NARDIELLO, S
    SAGNELLI, E
    SCHAFFNER, F
    VERNACE, S
    PARONETTO, F
    LIVER, 1983, 3 (04): : 207 - 212
  • [33] IMMUNOLOGICAL STATUS AS BASIS FOR APPROPRIATE TREATMENT IN SUBGROUPS OF HBSAG-POSITIVE CHRONIC HEPATITIS
    ARNOLD, W
    HESS, G
    HUTTEROTH, T
    MEYERZUMBUSCHENFELDE, KH
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1980, 15 (04) : 385 - 388
  • [34] CELL-MEDIATED-IMMUNITY AND IMMUNOSUPPRESSIVE THERAPY IN HBSAG-POSITIVE CHRONIC ACTIVE HEPATITIS
    PASTORE, G
    DENTICO, P
    BUONGIORNO, R
    ANGARANO, G
    SCHIRALDI, O
    TURSI, A
    LORIA, MP
    LANCET, 1979, 1 (8117): : 676 - 678
  • [35] THE DETRIMENTAL EFFECTS OF ADRENOCORTICOSTEROID THERAPY IN HBSAG-POSITIVE CHRONIC ACTIVE HEPATITIS - FACT OR ARTIFACT
    CONN, HO
    MADDREY, WC
    SOLOWAY, RD
    HEPATOLOGY, 1982, 2 (06) : 885 - 887
  • [36] REAFERON TREATMENT OF ACUTE HBSAG-POSITIVE VIRUS HEPATITIS
    GORBARETS, IP
    KETILADZE, ES
    FARBER, NA
    BUGAEVA, NP
    BRAGINSKY, DM
    SERGEEVA, NA
    KHLOPOVA, IN
    NEMTSOVA, EB
    KLINICHESKAYA MEDITSINA, 1990, 68 (03): : 65 - 68
  • [37] SERUM LEVELS OF HEPATITIS-B SURFACE AND CORE ANTIGENS DURING IMMUNOSUPPRESSIVE TREATMENT OF HBSAG-POSITIVE CHRONIC ACTIVE HEPATITIS
    SAGNELLI, E
    MANZILLO, G
    MAIO, G
    PASQUALE, G
    FELACO, FM
    FILIPPINI, P
    IZZO, CM
    PICCININO, F
    LANCET, 1980, 2 (8191): : 395 - 397
  • [38] EFFECT OF (+)-CYANIDANOL-3(CATERGEN) ON THE HBSAG CARRIER STATE AND HBSAG-POSITIVE CHRONIC ACTIVE HEPATITIS (CAH)
    MIHAS, AA
    HEPATOLOGY, 1983, 3 (05) : 842 - 842
  • [39] SCHOENLEIN-HENOCH PURPURA WITH HBSAG-POSITIVE CHRONIC HEPATITIS
    STEMEROWICZ, R
    MOLLER, B
    LOBECK, H
    OERTEL, J
    HOPF, U
    IMMUNITAT UND INFEKTION, 1988, 16 (01): : 12 - 15
  • [40] Predicting clinical outcomes in patients with HBsAg-positive chronic hepatitis
    Myron John Tong
    Thatcher Thi Huynh
    Surachate Siripongsakun
    Patrick Weijen Chang
    Lori Terese Tong
    Yen Phi Ha
    Edward Alphonso Mena
    Matthew Frank Weissman
    Hepatology International, 2015, 9 : 567 - 577
12345